<PAGE> 1
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
DATE OF REPORT (DATE OF EARLIEST EVENT REPORTED): January 7, 2001
CALIPER TECHNOLOGIES CORP.
(Exact name of registrant as specified in charter)
DELAWARE
(State or other jurisdiction of incorporation)
<TABLE>
<S> <C>
0-28229 33-0675808
(Commission File Number) (I.R.S. Employer Identification No.)
</TABLE>
605 FAIRCHILD DRIVE
MOUNTAIN VIEW, CA 94043-2234
(Address of principal executive offices and zip code)
(650) 623-0700
(Registrant's telephone number, including area code)
<PAGE> 2
Item 5. Other Events.
On January 7, 2001, Caliper announced that it had reached a comprehensive
settlement agreement with ACLARA BioSciences on all pending litigation between
the two companies. The press release announcing the settlement of the litigation
is filed as Exhibit 99.1 and incorporated by reference herein.
Item 7. Exhibits.
Exhibit 99.1. Press Release Dated January 7, 2001.
<PAGE> 3
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.
CALIPER TECHNOLOGIES CORP.
DATE: January 9, 2001 By: /s/ James L. Knighton
-------------------------------------
James L. Knighton
Vice President, Finance and
Chief Financial Officer
<PAGE> 4
INDEX TO EXHIBITS
Exhibit 99.1. Press Release Dated January 7, 2001.
